![Caroline Thielen](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Caroline Thielen
Directeur/Bestuurslid bij
Exevir Bio BV
Health Technology
Profiel
Caroline Thielen currently works at Exevir Bio BV, as Director, Dendrogenix SA, as Director, and Promethera Therapeutics SA, as Director.
Actieve functies van Caroline Thielen
| Bedrijven | Functie | Begin |
|---|---|---|
Exevir Bio BV
 Exevir Bio BV Pharmaceuticals: MajorHealth Technology Develops antibody-based therapies | Directeur/Bestuurslid | - |
Promethera Therapeutics SA
 Promethera Therapeutics SA Pharmaceuticals: OtherHealth Technology Provides cell therapies for treatment of liver diseases | Directeur/Bestuurslid | - |
Dendrogenix SA
 Dendrogenix SA Pharmaceuticals: MajorHealth Technology Develops molecules and dendrogenins to treat hormone-dependent breast cancer | Directeur/Bestuurslid | - |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Bedrijven in privébezit | 3 |
|---|---|
Exevir Bio BV
Exevir Bio BV Pharmaceuticals: MajorHealth Technology Develops antibody-based therapies | Health Technology |
Promethera Therapeutics SA
Promethera Therapeutics SA Pharmaceuticals: OtherHealth Technology Provides cell therapies for treatment of liver diseases | Health Technology |
Dendrogenix SA
Dendrogenix SA Pharmaceuticals: MajorHealth Technology Develops molecules and dendrogenins to treat hormone-dependent breast cancer | Health Technology |
